In a study published in Nature, researchers led by Prof. Hu Zheng from the Shenzhen Institutes of Advanced Technology (SIAT) ...

Fructose, the most common food sweetener, is widely used in processed sugary beverages, candies, and baked goods. Excessive ...

The most important takeaway from the study is that these data suggest that CD47 is an attractive target for drug development.

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

EXCLUSIVE - When Richard Nelson had his shock bowel cancer diagnosis he was offered a new innovative 'vaccine' clinical trial ...

However, recurrence following surgery is a major problem and is often the ultimate cause of death. Colorectal cancer can ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced the completion of a study ...

part of the Keck School of Medicine of USC The researchers knew colorectal cancer cells use the immune checkpoint CD47 to dodge macrophages, innate immune cells that would otherwise target and destroy ...

Scientists have uncovered how certain E. coli bacteria in the gut promote colon cancer by binding to intestinal cells and ...

A new USC study has found evidence that targeting CD47, a protein that is part of the innate immune system, could be a key step in fighting colorectal cancer. It is one of the first indications that ...

Metabolic enzymes, typically associated with energy production, are now discovered to also play essential roles in the nucleus, such as orchestrating cell division and DNA repair. This breakthrough, ...